ATH Ann: First Patient dosed in ATH434 Phase 2 Clinical Trial - 6th Jul 2022, 9:50am

annb0t

annb0t

Top 20
ATH Ann: First Patient dosed in ATH434 Phase 2 Clinical Trial
Price Sensitive: Y
Date: 6th Jul 2022, 9:50am

>>> Read announcement: Google: ATH Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
ATH Ann: First Patient Enrolled in Australia in global Phase 2 Trial - 10th May 2023, 9:37am
Replies
0
Views
101
annb0t
annb0t
annb0t
ATH Ann: First Patient Enrolled in UK in Phase II Clinical Trial - 4th Apr 2023, 10:38am
Replies
0
Views
130
annb0t
annb0t
annb0t
ATH Ann: First Patient Enrolled in USA in Phase II Clinical Trial - 16th Mar 2023, 10:12am
Replies
0
Views
129
annb0t
annb0t
annb0t
ATH Ann: First Patient Enrolled in Europe in Phase II Clinical trial - 8th Mar 2023, 9:19am
Replies
0
Views
121
annb0t
annb0t
annb0t
ATH Ann: Notice of Annual General Meeting/Proxy Form - 31st Oct 2023, 12:25pm
Replies
0
Views
105
annb0t
annb0t
Top Bottom